Virtus Investment Advisers’s Eli Lilly LLY Stock Holding History

Virtus Investment Advisers’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49M	Buy	2,074 +248	+14%	+$253K	0.58%	18
2026 Q1	$1.68M	Buy	+1,826	New	+$1.85M	0.46%	87
2025 Q3	–	Sell	-1,565	Closed	-$1.22M	–	459
2025 Q2	$1.22M	Sell	1,565 -202	-11%	-$157K	0.41%	132
2025 Q1	$1.46M	Buy	1,767 +1,567	+784%	+$1.3M	0.4%	42
2024 Q4	$154K	Buy	+200	New	+$166K	0.12%	221
2024 Q3	–	Sell	-288	Closed	-$261K	–	363
2024 Q2	$261K	Sell	288 -162	-36%	-$130K	0.22%	139
2024 Q1	$350K	Buy	+450	New	+$320K	0.25%	114
2023 Q1	–	Sell	-836	Closed	-$306K	–	315
2022 Q4	$306K	Hold	836	–	–	0.2%	147
2022 Q3	$270K	Buy	+836	New	+$265K	0.12%	162
2018 Q1	–	Sell	-4,088	Closed	-$345K	–	259
2017 Q4	$345K	Sell	4,088 -97	-2%	-$8.25K	0.04%	337
2017 Q3	$358K	Sell	4,185 -573	-12%	-$47K	0.04%	347
2017 Q2	$392K	Sell	4,758 -879	-16%	-$71.7K	0.04%	350
2017 Q1	$474K	Buy	+5,637	New	+$451K	0.04%	336
2016 Q4	–	Sell	-32,407	Closed	-$2.6M	–	509
2016 Q3	$2.6M	Buy	+32,407	New	+$2.59M	0.17%	186

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtus Investment Advisers's LLY Position: Q2 2026 in Review

Virtus Investment Advisers increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $253K and bringing the position to 2,074 shares worth $2.49M. The position accounts for 0.58% of the portfolio, ranked #18.

Virtus Investment Advisers first reported a position in LLY in Q3 2016 and has held it in 14 quarters since. The position peaked at $2.6M in Q3 2016. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Virtus Investment Advisers held 2,074 shares of Eli Lilly worth $2.49M as of Q2 2026.
Virtus Investment Advisers bought 248 Eli Lilly shares in Q2 2026, an estimated $253K.
Eli Lilly made up 0.58% of Virtus Investment Advisers's portfolio in Q2 2026, its #18 holding.
Virtus Investment Advisers first reported a position in Eli Lilly in Q3 2016 and has held it in 14 quarters since.
Virtus Investment Advisers's Eli Lilly position peaked at $2.6M in Q3 2016.
4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.